AR064150A1 - Derivados antibacterianos de quinolina - Google Patents
Derivados antibacterianos de quinolinaInfo
- Publication number
- AR064150A1 AR064150A1 ARP070105443A ARP070105443A AR064150A1 AR 064150 A1 AR064150 A1 AR 064150A1 AR P070105443 A ARP070105443 A AR P070105443A AR P070105443 A ARP070105443 A AR P070105443A AR 064150 A1 AR064150 A1 AR 064150A1
- Authority
- AR
- Argentina
- Prior art keywords
- alkyl
- mono
- aryl
- het
- optionally substituted
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/465—Nicotine; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
- A61K31/47—Quinolines; Isoquinolines
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
- A61P31/06—Antibacterial agents for tuberculosis
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Pulmonology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
Abstract
Los compuestos reivindicados son utiles para el tratamiento de una infeccion bacteriana. También se reivindica una composicion que comprende un portador farmacéuticamente aceptable y, como ingrediente activo, una cantidad terapéuticamente efectiva de los compuestos reivindicados, el uso de los compuestos o composiciones reivindicadas para la elaboracion de un medicamento para el tratamiento de una infeccion bacteriana y un proceso para preparar los compuestos reivindicados. Reivindicacion 1: Un compuesto de la formula (1a) o (1b) incluyendo cualquier forma estereoquímicamente isomérica del mismo, en donde p es un entero igual a 1, 2, 3 o 4; q es un entero igual a cero, 1, 2, 3 o 4; R1 es hidrogeno, ciano, formilo, carboxilo, halo, alquenilo C2-6, alquinilo C2-6, haloalquilo, hidroxi, alquiloxi, alquiltio, alquiltioalquilo, -C=N-OR11, amino, mono o di(alquil)amino, aminoalquilo, mono o di(alquil)aminoalquilo, alquilcarbonilaminoalquilo, aminocarbonilo, mono o di(alquil)aminocarbonilo, arilalquilo, arilcarbonilo, R5aR4aNalquilo, di(aril)alquilo, arilo, R5aR4aN-, R5aR4aN-C(=O)-, o Het; R2 es hidrogeno, alquiloxi, arilo, ariloxi, hidroxi, mercapto, alquiloxialquiloxi, alquiltio, mono o di(alquil)amino, pirrolidino o un radical de la formula (2) en donde Y es CH2, O, S, NH o N-alquilo; R3 es alquilo, arilalquilo, aril-O-alquilo, aril-alquil-O-alquilo, aril-arilo, Het, Het-alquilo, Het-O-alquilo, Het-alquil-O-alquilo o un radical de la formula (3); R4 y R5 cada uno independientemente es hidrogeno; alquilo; alquiloxialquilo; arilalquilo; Het-alquilo; mono- o dialquilaminoalquilo; biciclo[2.2.1]heptilo; Het; arilo; o -C(=NH)-NH2; o R4 y R5 conjuntamente con el átomo de nitrogeno al cual ellos están unidos forman un radical seleccionado del grupo integrado por pirrolidino, piperidino, piperazino, morfolino, 4-tiomorfolino, 1,1-dioxido-tiomorfolinilo, azetidinilo, 2,3-dihidroisoindol-1-ilo, tiazolidin-3-ilo, 1,2,3,6-tetrahidropiridilo, hexahidro-1H-azepinilo, hexahidro-1H-1,4-diazepinilo, hexahidro-1,4-oxazepinilo, 1,2,3,4-tetrahidroisoquinolin-2-ilo, 2,5-diazabiciclo[2.2.1]heptilo, pirrolinilo, pirrolilo, imidazolidinilo, pirazolidinilo, 2-imidazolinilo, 2-pirazolinilo, imidazolilo, pirazolilo, triazolilo, piridinilo, piridazinilo, pirimidinilo, pirazinilo y triazinilo, cada radical opcionalmente sustituido con 1, 2, 3 o 4 sustituyentes, cada sustituyente independientemente seleccionado de alquilo, haloalquilo, alquilcarbonilo, halo, arilalquilo, hidroxi, alquiloxi, amino, mono o dialquilamino, aminoalquilo, mono o dialquilaminoalquilo, alquiltio, alquiltioalquilo, arilo, piridilo, pirimidinilo, piperidinilo opcionalmente sustituido con alquilo o pirrolidinilo opcionalmente sustituido con arilalquilo; R4a y R5a conjuntamente con el átomo de nitrogeno al cual ellos están unidos forman un radical seleccionado del grupo integrado por pirrolidino, piperidino, piperazino, morfolino, 4- tiomorfolino, 2,3-dihidroisoindol-1-ilo, tiazolidin-3-ilo, 1,2,3,6-tetrahidropiridilo, hexahidro-1H-azepinilo, hexahidro-1H-1,4-diazepinilo, hexahidro-1,4-oxazepinilo, 1,2,3,4-tetrahidroisoquinolin-2-ilo, pirrolinilo, pirrolilo, imidazolidinilo, pirazolidinilo, 2-imidazolinilo, 2-pirazolinilo, imidazolilo, pirazolilo, triazolilo, piridinilo, piridazinilo, pirimidinilo, pirazinilo y triazinilo, cada radical opcionalmente sustituido con 1, 2, 3 o 4 sustituyentes, cada sustituyente independientemente seleccionado de alquilo, haloalquilo, halo, arilalquilo, hidroxi, alquiloxi, amino, mono o dialquilamino, alquiltio, alquiltioalquilo, arilo, piridilo o pirimidinilo; R6 es arilo1 o Het; R7 es hidrogeno, halo, alquilo, arilo o Het; R8 es hidrogeno o alquilo; R9 es oxo; o R8 y R9 conjuntamente forman el radical -CH=CH-N=; R10 es hidrogeno, alquilo C1-6 o arilalquilo C1-6; R11 es hidrogeno o alquilo; Z es S o NR10; arilo es un homociclo seleccionado de fenilo, naftilo, acenaftilo o tetrahidronaftilo, estando cada uno opcionalmente sustituido con 1, 2 o 3 sustituyentes, estando cada sustituyente independientemente seleccionado de hidroxi, halo, ciano, nitro, amino, mono o dialquilamino, alquilo, alquenilo C2-6 opcionalmente sustituido con fenilo, haloalquilo, alquiloxi, haloalquiloxi, carboxilo, alquiloxicarbonilo, aminocarbonilo, morfolinilo o mono o dialquilaminocarbonilo; arilo1 es un homociclo seleccionado de fenilo, naftilo, acenaftilo o tetrahidronaftilo, estando cada uno opcionalmente sustituido con 1, 2 o 3 sustituyentes, estando cada sustituyente independientemente seleccionado de hidroxi, halo, ciano, nitro, amino, mono o dialquilamino, alquilo, haloalquilo, alquiloxi, alquiltio, haloalquiloxi, carboxilo, alquiloxicarbonilo, aminocarbonilo, morfolinilo, Het o mono o dialquilaminocarbonilo; Het es un heterociclo monocíclico seleccionado de N-fenoxipiperidiniIo, piperidinilo, pirrolilo, pirazolilo, imidazolilo, furanilo, tienilo, oxazolilo, isoxazolilo, tiazolilo, isotiazolilo, piridinilo, pirimidinilo, pirazinilo o piridazinilo; o un heterociclo bicíclico seleccionado de quinolinilo, quinoxalinilo, indolilo, benzimidazolilo, benzoxazolilo, benzisoxazolilo, benzotiazolilo, benzisotiazolilo, benzofuranilo, benzotienilo, 2,3-dihidrobenzo[1,4]dioxinilo o benzo[1,3]dioxolilo; estando cada heterociclo monocíclico y bicíclico opcionalmente sustituido con 1, 2 o 3 sustituyentes, cada sustituyente independientemente seleccionado de halo, hidroxi, alquilo o alquiloxi; un N-oxido del mismo, una sal farmacéuticamente aceptable del mismo o un solvato del mismo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP06125521 | 2006-12-06 |
Publications (1)
Publication Number | Publication Date |
---|---|
AR064150A1 true AR064150A1 (es) | 2009-03-18 |
Family
ID=37944337
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ARP070105443A AR064150A1 (es) | 2006-12-06 | 2007-12-05 | Derivados antibacterianos de quinolina |
Country Status (30)
Country | Link |
---|---|
US (1) | US7998979B2 (es) |
EP (1) | EP2086941B1 (es) |
JP (1) | JP5356245B2 (es) |
KR (1) | KR101490221B1 (es) |
CN (1) | CN101541752B (es) |
AR (1) | AR064150A1 (es) |
AT (1) | ATE465994T1 (es) |
AU (1) | AU2007328889B2 (es) |
BR (1) | BRPI0720251B8 (es) |
CA (1) | CA2668520C (es) |
CL (1) | CL2007003516A1 (es) |
CY (1) | CY1110706T1 (es) |
DE (1) | DE602007006231D1 (es) |
DK (1) | DK2086941T3 (es) |
ES (1) | ES2344535T3 (es) |
HK (1) | HK1137428A1 (es) |
HR (1) | HRP20100384T1 (es) |
IL (1) | IL199081A (es) |
JO (1) | JO2685B1 (es) |
ME (1) | ME01073B (es) |
MX (1) | MX2009005980A (es) |
NO (1) | NO341995B1 (es) |
NZ (1) | NZ576673A (es) |
PL (1) | PL2086941T3 (es) |
PT (1) | PT2086941E (es) |
RS (1) | RS51390B (es) |
RU (1) | RU2446159C2 (es) |
SI (1) | SI2086941T1 (es) |
TW (1) | TWI412364B (es) |
WO (1) | WO2008068269A1 (es) |
Families Citing this family (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EA038350B1 (ru) | 2012-04-27 | 2021-08-12 | Янссен Фармацевтика Нв | Антибактериальные хинолиновые производные |
ES2576491T3 (es) | 2012-04-27 | 2016-07-07 | Janssen Pharmaceutica, N.V. | Derivados de quinolina antibacterianos |
CN104650054B (zh) * | 2013-11-25 | 2019-09-13 | 重庆医药工业研究院有限责任公司 | 一种抗结核菌的喹啉噻吩芳氧乙胺衍生物 |
US11857352B2 (en) | 2016-09-06 | 2024-01-02 | The Research Foundation For The State University Of New York | Positron imaging tomography imaging agent composition and method for bacterial infection |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS6033389B2 (ja) * | 1979-02-22 | 1985-08-02 | 日産化学工業株式会社 | 複素環エ−テル系フェノシキ脂肪酸誘導体、その製造法および該誘導体を含有する除草剤 |
CA2270123A1 (en) | 1996-10-28 | 1998-05-07 | Department Of The Army, U.S. Government | Compounds, compositions and methods for treating antibiotic-resistant infections |
MXPA04000968A (es) * | 2001-07-31 | 2005-02-17 | Univ Wayne State | Derivados de quinolina y uso de los mismos como agentes antitumor. |
PL222801B1 (pl) | 2002-07-25 | 2016-09-30 | Janssen Pharmaceutica Nv | Pochodne chinoliny, ich zastosowanie, sposób ich wytwarzania oraz kompozycja farmaceutyczna zawierająca je |
AP2188A (en) | 2004-01-23 | 2010-12-14 | Janssen Pharmaceutica Nv | Substituted quinolines and their use as mycobacterial inhibitors. |
PT1711181E (pt) | 2004-01-23 | 2009-12-29 | Janssen Pharmaceutica Nv | Derivados quinolina e sua utilização como inibidores micobacterianos |
AU2005210036B2 (en) * | 2004-01-29 | 2010-12-23 | Janssen Pharmaceutica N.V. | Quinoline derivatives for use as mycobacterial inhibitors |
EP1753427B1 (en) * | 2004-05-28 | 2008-04-02 | Janssen Pharmaceutica N.V. | Use of substituted quinoline derivatives for the treatment of drug resistant mycobacterial diseases |
DK1797115T3 (en) | 2004-09-28 | 2017-10-02 | Janssen Pharmaceutica Nv | BACTERIAL ATP SYNTHASE BINDING DOMAIN. |
-
2007
- 2007-11-29 JO JO2007507A patent/JO2685B1/en active
- 2007-12-04 JP JP2009539740A patent/JP5356245B2/ja not_active Expired - Fee Related
- 2007-12-04 KR KR1020097012572A patent/KR101490221B1/ko active IP Right Grant
- 2007-12-04 PL PL07847813T patent/PL2086941T3/pl unknown
- 2007-12-04 BR BRPI0720251A patent/BRPI0720251B8/pt active IP Right Grant
- 2007-12-04 DK DK07847813.8T patent/DK2086941T3/da active
- 2007-12-04 MX MX2009005980A patent/MX2009005980A/es active IP Right Grant
- 2007-12-04 PT PT07847813T patent/PT2086941E/pt unknown
- 2007-12-04 CN CN2007800437666A patent/CN101541752B/zh active Active
- 2007-12-04 EP EP07847813A patent/EP2086941B1/en active Active
- 2007-12-04 ME MEP-2010-111A patent/ME01073B/me unknown
- 2007-12-04 DE DE602007006231T patent/DE602007006231D1/de active Active
- 2007-12-04 SI SI200730286T patent/SI2086941T1/sl unknown
- 2007-12-04 AT AT07847813T patent/ATE465994T1/de active
- 2007-12-04 RS RSP-2010/0340A patent/RS51390B/en unknown
- 2007-12-04 AU AU2007328889A patent/AU2007328889B2/en not_active Ceased
- 2007-12-04 US US12/516,370 patent/US7998979B2/en active Active
- 2007-12-04 WO PCT/EP2007/063315 patent/WO2008068269A1/en active Application Filing
- 2007-12-04 ES ES07847813T patent/ES2344535T3/es active Active
- 2007-12-04 NZ NZ576673A patent/NZ576673A/en unknown
- 2007-12-04 RU RU2009125525/04A patent/RU2446159C2/ru active
- 2007-12-04 CA CA2668520A patent/CA2668520C/en active Active
- 2007-12-05 AR ARP070105443A patent/AR064150A1/es unknown
- 2007-12-05 TW TW096146213A patent/TWI412364B/zh active
- 2007-12-05 CL CL200703516A patent/CL2007003516A1/es unknown
-
2009
- 2009-06-02 IL IL199081A patent/IL199081A/en active IP Right Grant
- 2009-07-06 NO NO20092540A patent/NO341995B1/no unknown
-
2010
- 2010-01-28 HK HK10100936.5A patent/HK1137428A1/xx not_active IP Right Cessation
- 2010-07-12 HR HR20100384T patent/HRP20100384T1/hr unknown
- 2010-07-28 CY CY20101100708T patent/CY1110706T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AR064151A1 (es) | Derivados de quinolina antibacterianos, composiciones farmaceuticas que los contienen y metodo de preparacion. | |
AR064153A1 (es) | Derivados de quinolina antibacterianos. procesos de obtencion y composiciones farmaceuticas. | |
RS52431B (en) | QUINOLINE DERIVATIVES AND THEIR USE AS MYCOBACTERIAL INHIBITORS | |
AR054889A1 (es) | Derivados de quinolina como agentes bacterianos | |
HRP20190947T1 (hr) | Heterociklički spoj | |
RU2008112290A (ru) | Производные пиридазинона, используемые для лечения боли | |
AR049127A1 (es) | Uso de derivados quinolina sustituidos para el tratamiento de enfermedades micobacterianas resistentes a los farmacos | |
AR051790A1 (es) | Tratamiento de tuberculosis latente | |
AR079904A1 (es) | Derivados de triazol sustituidos como moduladores de la gamma secretasa | |
AR057911A1 (es) | Compuestos de pirimidinil benzotiofeno formulacion farmaceutica que lo comprende y su uso para la manufactura de un medicamento | |
NZ626068A (en) | Multicyclic compounds and methods of use thereof | |
PE20121815A1 (es) | Compuestos de pirrolo-pirimidina como inhibidores de cdk4/6 | |
AR035991A1 (es) | Derivados de benzimidazoles e imidazopiridinas, un procedimiento para su preparacion, composiciones farmaceuticas, un procedimiento para su preparacion, y un medicamento utiles como inhibidores de la replicacion del virus sincitial respiratorio | |
NZ605528A (en) | Ip receptor agonist heterocyclic compounds | |
AR080754A1 (es) | Derivados de imidazo (1,2-a) pirazina y su uso como inhibidores de pde10 | |
AR078841A1 (es) | Derivados de imidazo(1,2-b) piridazina y su uso como inhibidores de pde10 | |
AR083339A1 (es) | Compuestos de quinazolina como bloqueadores de los canales de sodio | |
WO2006078621A3 (en) | 2-phenoxy-n- (1, 3 , 4-thiadizol-2-yl) pyridin-3-amine derivatives and related compounds as p2y1 receptor inhibitors for the treatment of thromboembolic disorders | |
AR054587A1 (es) | Derivados de quinolina antibacterianos | |
JP2010511667A5 (es) | ||
AR054272A1 (es) | Derivados de 3- aminopirrilidinas tri, tetra - sustituidos | |
HRP20110540T1 (hr) | Antibakterijski derivati kinolina | |
AR052019A1 (es) | COMPUESTOS HETEROCICLICOS, PROCESOS DE PREPARACIoN Y MÉTODO PARA TRATAR ENFERMEDADES HIPERPROLIFERATIVAS | |
AR064150A1 (es) | Derivados antibacterianos de quinolina | |
AR059018A1 (es) | Derivados de 6- fenil -1h- imidazo (4,5-c) piridina -4- carbonitrilo y su uso en el tratamiento de enfermedades relacionadas con catepsina s y/o catepsina k |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FB | Suspension of granting procedure |